Original Articles
Beta-Adrenergic Receptor Polymorphisms and Cardiac Graft Function in Potential Organ Donors

https://doi.org/10.1111/j.1600-6143.2012.04266.xGet rights and content
Under a Creative Commons license
open archive

Prior studies have demonstrated associations between beta-adrenergic receptor (βAR) polymorphisms and left ventricular dysfunction—an important cause of allograft nonutilization for transplantation. We hypothesized that βAR polymorphisms predispose donor hearts to LV dysfunction after brain death. A total of 1043 organ donors managed from 2001–2006 were initially studied. The following βAR single nucleotide polymorphisms were genotyped: β1AR 1165C/G (Arg389Gly), β1AR 145A/G (Ser49Gly), β2AR 46G/A (Gly16Arg) and β2AR 79C/G (Gln27Glu). In multivariable regression analyses, the β2AR46 SNP was significantly associated with LV systolic dysfunction, with each minor allele additively decreasing the odds for LV ejection fraction <50%. The β1AR1165 and β2AR46 SNPs were associated with higher dopamine requirement during the donor management period: donors with the GG and AA genotypes had ORs of 2.64 (95% CI 1.52–4.57) and 2.70 (1.07–2.74) respectively for requiring >10 μg/kg/min of dopamine compared to those with the CC and GG genotypes. However, no significant associations were found between βAR SNPs and cardiac dysfunction in 364 donors managed from 2007–2008, perhaps due to changes in donor management, lack of power in this validation cohort, or the absence of a true association. βAR polymorphisms may be associated with cardiac dysfunction after brain death, but these relationships require further study in independent donor cohorts.

Key words:

Allograft function
brain death
cardiac allograft
cardiac transplant
cohort study
donor evaluation
donor management
donor outcomes
genetic polymorphism
genotyping

Abbreviations:

βAR
beta-adrenergic receptor
CTDN
California Transplant Donor Network
HWE
Hardy Weinberg Equilibrium
LV
left ventricular
LVEF
left ventricular ejection fraction
RWMA
regional wall motion abnormalities
SNP
single nucleotide polymorphism

Cited by (0)